Login to Your Account



Pharma: Clinic Roundup


Wednesday, July 18, 2012
• Grifols SA, of Barcelona, Spain, said it plans to start a safety trial of an inhaled formulation of alpha1-proteinase inhibitor later this year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription